Clinical Trial Update: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating neointimal coverage after implantation of a Biolimus-eluting stent with biodegradable polymer. The study uses optical coherence …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Stable Angina

Drugs mentioned

• Biolimus-eluting stent with biodegradable polymer (Biolimus A9-eluting stent)

Snippet

Sponsor: Yonsei University | Conditions: Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension | Phase 4 | Status: COMPLETED